Related Experiment Video

Updated: May 26, 2026

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

A p.R369G POLG2 mutation associated with adPEO and multiple mtDNA deletions causes decreased affinity between

Kate Craig1, Matthew J Young, Emma L Blakely

  • 1Mitochondrial Research Group, Institute for Ageing and Health, The Medical School, Framlington Place, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.

Mitochondrion
|December 14, 2011
PubMed

Insights

A novel POLG2 mutation (p.R369G) causes adPEO by impairing mitochondrial DNA polymerase gamma holoenzyme function. This study reveals a new mechanism for mitochondrial genome instability and disease.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Human mitochondrial DNA (mtDNA) is replicated by polymerase gamma (pol γ), essential for mitochondrial genome integrity.
  • Pol γ consists of a catalytic p140 subunit and a p55 accessory subunit encoded by POLG2.
  • Mutations in POLG2 can lead to mitochondrial disorders.

Observation:

  • A patient with adPEO and multiple mtDNA deletions presented with a potential dominant POLG2 mutation (p.R369G).
  • The study focused on the molecular characterization of this specific mutation.
  • Biochemical analysis was performed on the recombinant mutant p55 protein.

Findings:

  • The p.R369G mutation in the p55 subunit reduced its affinity for the p140 catalytic subunit of pol γ.
  • This interaction defect led to impaired processivity of the holoenzyme complex.
  • The mutant protein did not exhibit sensitivity to N-ethylmalaimide (NEM) inhibition, suggesting a distinct pathogenic mechanism.

Implications:

  • This research identifies a novel disease mechanism for mitochondrial disorders linked to POLG2 mutations.
  • Understanding these molecular defects can inform future therapeutic strategies for adPEO and related conditions.
  • The findings contribute to the broader knowledge of mitochondrial DNA replication and maintenance.

More Related Videos

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease09:34

Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease

Published on: April 4, 2018

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing07:24

Genotyping Single Nucleotide Polymorphisms in the Mitochondrial Genome by Pyrosequencing

Published on: February 10, 2023

Related Concept Videos

RNA Editing02:23

RNA Editing

RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Proofreading01:31

Proofreading

Synthesis of new DNA molecules is carried out by the enzyme DNA polymerase, which adds nucleotides on the daughter strand complementary to the template DNA strand. DNA polymerase has a higher affinity to add the correct base and ensures fidelity during DNA replication. Furthermore,  it exhibits proofreading activity during replication, using an exonuclease domain that cuts off incorrect nucleotides from the nascent DNA strand.
Errors During Replication are Corrected by the DNA Polymerase Enzyme
Proofreading01:43

Proofreading

Overview